Cintia Piccina
About Cintia Piccina
Cintia Piccina is a seasoned pharmaceutical executive with extensive experience in commercial, marketing, and sales roles, particularly in oncology and gene therapy.
Cintia Piccina Education and Expertise
Cintia Piccina holds a Doctorate in Pharmacy and Biochemistry from the University of Sao Paulo, Brazil. She also has an M.B.A. from the Escola Superior de Propaganda e Marketing in Sao Paulo. Her academic credentials underline a robust foundation in both scientific and business disciplines, which have proven essential in her professional career across multiple high-level roles in the biopharmaceutical industry.
Cintia Piccina Role at AlloVir
Cintia Piccina served as the Chief Commercial Officer at AlloVir. In this role, she was responsible for the commercial strategy and operations, including market access, sales, and marketing functions. Her leadership at AlloVir involved driving the commercial execution of the company's therapeutic solutions.
Cintia Piccina Head of Commercial at 2Seventy Bio
At 2Seventy Bio, Cintia Piccina was the Head of Commercial. Her role involved overseeing all commercial activities, focusing on market strategy and commercial operations to ensure successful product launches and market penetration. Her strategic direction facilitated the company's growth in the biopharma sector.
Cintia Piccina SVP Commercial Oncology and US General Manager at bluebird bio
Cintia Piccina held the position of Senior Vice President of Commercial Oncology and US General Manager at bluebird bio. In this capacity, she managed commercial operations, particularly in the oncology segment, and directed U.S. market activities. Her role was pivotal in advancing the company's oncology portfolio and increasing its market presence.
Cintia Piccina Career at Novartis
Cintia Piccina worked at Novartis for over 20 years, holding various positions in commercial, marketing, and sales roles. She ultimately served as Vice President of the Global Oncology Cell and Gene Strategy & Program Management Office. Her extensive experience at Novartis included strategic planning and implementation in oncology and cell and gene therapy, contributing significantly to the company's global success in these areas.